Ohio's Proposed Ban On Sales Marks Kratom Industry's Latest Battlefront

Ohio Board of Pharmacy proposes placing into Schedule I kratom constituent ingredients mitragynine and 7-hydroxymitragynine, a change that would prohibit kratom sales in the state. The board's findings "parrot the false propaganda" of FDA in its "crusade to ban kratom," says the American Kratom Association.

State Law_484086778 _1200.jpg

Add Ohio's pharmacy board to the public agencies the American Kratom Association is lobbying to prevent a ban on sales of products containing kratom, a botanical in the coffee family native to Southeast Asia.

More from Regulation

EU Probiotics Deadlock: Ombudsman Finds ‘No Maladministration’ By The Commission

 
• By 

In response to an IPA Europe complaint, European Ombudsman Emily O’Reilly finds that the Commission’s interpretation of EU food legislation in relation to probiotics is “reasonable and in line with the main goal of this legislation, which is to ensure a high level of consumer protection.”

US ‘Healthy’ Labeling Rule Applies To Supplements While Acknowledging Structure/Function Claim Use

Vitamin, mineral and supplement products “may bear nutrient content claims, including ‘healthy,’’ if they meet structure/function claim criteria “without being subject to the requirements of the ‘healthy nutrient content claim” stated in the final rule FDA published recently.

UK Finds Turmeric Supplements Pose Risk To Health

 
• By 

UK food toxicity committee says substantial exceedances of the Acceptable Daily Intake of turmeric - such as through excessive supplement use - represents a potential health risk to humans.

Texas Opens Door On 2025 State Legislation To Age-Restrict Sales Of Supplements, OTCs

 

Texas bill filed in advance of the state’s next legislative session starting in January while bills proposing prohibiting sales of supplements and OTC drugs for weight loss or bodybuilding to minors remain active in three states where current sessions continue, Massachusetts, Michigan and New Jersey.

More from Policy & Regulation

OTC ACNU Final Rule Publication In December Included In US FDA’s Latest Regulatory Goals List

 

Latest regulatory goals update also includes April as target date for final rule on exemptions from IND clearance for clinical trials to evaluate food, dietary supplements or cosmetics and May for an NPRM would recognize N-acetyl-L-cysteine as a lawful dietary ingredient.

First UK CBD Novel Food Authorizations Expected In 2025

 
• By 

FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.

Amway Survey Shows US Consumers Commonly Believe Supplements Have Premarket Approval

 

Direct-selling giant say “despite widespread use, nearly half of respondents – 47% – mistakenly believe that the FDA approves these products before they are sold to the public.”